Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FWP

Forward Pharma A/S (FWP) Stock Price, News & Analysis

Forward Pharma A/S logo

About Forward Pharma A/S Stock (NASDAQ:FWP)

Advanced Chart

Key Stats

Today's Range
$1.95
$1.95
50-Day Range
$1.79
$3.19
52-Week Range
$1.50
$6.48
Volume
N/A
Average Volume
7,484 shs
Market Capitalization
$13.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Receive FWP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

FWP Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
Firebrick Pharma’s Strategic Moves Boost Market Position
See More Headlines

FWP Stock Analysis - Frequently Asked Questions

Forward Pharma A/S (NASDAQ:FWP) released its quarterly earnings data on Thursday, September, 1st. The biotechnology company reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.26) by $0.06.

Based on aggregate information from My MarketBeat watchlists, some other companies that Forward Pharma A/S investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Akari Therapeutics (AKTX), Aldeyra Therapeutics (ALDX) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
9/01/2016
Today
5/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FWP
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$10.09 per share
Price / Book
0.19

Miscellaneous

Free Float
2,023,000
Market Cap
$13.83 million
Optionable
Not Optionable
Beta
1.38

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:FWP) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners